Belladonna and Sacroiliitis - a phase IV clinical study of FDA data
Summary:
We study 4,333 people who take Belladonna (belladonna) or have Sacroiliitis. No report of Sacroiliitis is found in people who take Belladonna.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Belladonna?
Belladonna has active ingredients of belladonna. It is often used in irritable bowel syndrome. eHealthMe is studying from 1,043 Belladonna users. Check the latest studies of Belladonna.
What is Sacroiliitis?
Sacroiliitis (an inflammation of the sacroiliac joint) is found to be associated with 325 drugs and 525 conditions by eHealthMe. Check the latest studies of Sacroiliitis.
No report is found.
Do you take Belladonna and have Sacroiliitis?
- Check whether Sacroiliitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Belladonna:
- Belladonna (1,043 reports)
Sacroiliitis treatments and more:
- Sacroiliitis (3,290 reports)
How severe was Sacroiliitis and when was it recovered:
Expand to all the drugs that have ingredients of belladonna:
Browse all side effects of Belladonna:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Sacroiliitis:
Browse all the conditions that are associated with Sacroiliitis:
How the study uses the data?
The study uses data from the FDA. It is based on belladonna (the active ingredients of Belladonna) and Belladonna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Vfend cause Adrenal Insufficiency? - a second ago
- Drug interactions of Testosterone Cypionate and Kesimpta - 3 seconds ago
- Could Glutamic Acid cause Stress And Anxiety? - 5 seconds ago
- Drug interactions of Foradil and Magnesium - 9 seconds ago
- Could Avandia cause Right Atrial Dilatation? - 10 seconds ago
- Could Vitamin C cause Rash Pustular? - 13 seconds ago
- Could Micardis cause Blister? - 14 seconds ago
- Praluent and Nasal Decongestion Therapy for Women aged 60+ - 17 seconds ago
- Praluent and Stuffy Nose for Women aged 60+ - 18 seconds ago
- Praluent and Nose - Congested for Women aged 60+ - 18 seconds ago